SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Evofem at Critical Stretch with Potential New Birth Control
BIOTECH: Contraceptive Gel Is Part of CEO's Health Mission for WomenEvofem Biosciences wants to be the next big thing in birth control. After a long road, the San Diego biotech finds itself in a pivotal stretch.Ra Medical Announces Leadership Change, Delays Results
BIOTECH: CEO Irwin Is Out; CFO Jackson Named Interim Leader
Amid legal, manufacturing and financial problems Ra Medical Systems delayed the release of second quarter results.
Biotechs (And Other Small Companies) May Lose Association Insurance Option
In a July letter to insurers the California Department of Managed Care, or CDMC, fired a warning shot against association health plans, in what could have wide-reaching impacts for biotechs, life sciences trade groups and other industries.
Renovation Caters to Biotech’s Researchers
PROPERTY: Execs’ Offices Take Back Seat to Workers’
Give the best views of the ocean and surrounding landscape to the researchers up front.
Cell Therapy Company Changes Name and Relocates HQ to Carlsbad
Lineage Underwent Corporate Restructuring, Co. to Focus on 3 Programs
BioTime is getting a new name — and a new headquarters.
Lyford Named to California’s Aging Stakeholder Advisory Committee
Shelley Lyford, the CEO of the nonprofit West Health, has been appointed to California’s Master Plan for Aging Stakeholder Advisory Committee.
Telemedicine Blossoming at San Diego Hospitals Amid Payment Reforms
Virtual Care Opens Lines Of Communication, Healing
Telemedicine is by no means new. But lagging insurance coverage and infrastructure costs prevented wide adoption. That’s changing,
Ionis’ Spinraza Gets Some Competition From Novartis’ SMA Treatment
Ionis Having Good Discussions With FDA on Other Therapeutic
Ionis Pharmaceuticals’ drug for a muscle-wasting disease continues to be the company’s main driver of growth, with competition looming.
Ra Medical Terminates CEO, Delays Q2 Results
Amid legal, manufacturing and financial challenges Ra Medical Systems delayed the release of second quarter results and fired its CEO.
Scripps Health Breaks Ground on $59M Cancer Center
A $59 million cancer center on the campus of Scripps Mercy Hospital that’s geared toward the central and southern parts of San Diego recently broke ground.
Q2 Life Sciences Footprint Expands By 263,399 Square Feet
Expansions By Some Of the Bigger Players Are Expected in Q3
The leasing footprint of San Diego life sciences companies grew by 263,399 square feet in the second quarter, according to report from the brokerage firm JLL.
Halozyme Reports Q2 Results
San Diego-based Halozyme reported $39.1 million in second quarter revenue, an 11% year-over-year increase.
Organovo Suspends Lead Program, to Explore ‘Strategic Alternatives’
Known for 3-D printed tissues that emulate human organs, Organovo plans to explore a merger, acquisition and other strategic alternatives.
Midstage Trial Results Hit Mark for Cidara’s Anti-Fungal Drug
CEO Says Treatment Is Now One Step Closer to the Market
A drug candidate from Cidara Therapeutics aimed at invasive fungal infections hit its mark in midstage clinical trial results, the company recently reported.
With Legal Issues Settled, Arcturus Focuses on Medicines
MEDICINE: RNA Delivery System Could Bring In $1B, Company has Drug Development Pipeline As Well
Arcturus Therapeutics went through a messy proxy fight last year that saw the removal and then return of its CEO. With that chapter behind it, the company is vying to be a frontrunner in what could be the next big thing in drug development.
Obalon Therapeutics Charts $15M Stock Offering
Obalon Therapeutics – which makes a gas-filled balloon designed to treat obesity -- recently announced it’s planning a $15 million public stock offering.
Prev Next